Incident Noninfectious Uveitis Risk after Immune Checkpoint Inhibitor Treatment

被引：7

作者：

Chang, Myung Soo ^{[1
]}

Lee, Seung Won ^{[2
]}

Kim, Sunyeup ^{[3
]}

Lee, Christopher Seungkyu ^{[1
]}

Byeon, Suk Ho ^{[1
]}

Kim, Sung Soo ^{[1
]}

Kim, Yong Joon ^{[1
]}

机构：

[1] Yonsei Univ, Coll Med, Inst Vis Res, Dept Ophthalmol, Seodaemungu Yonseiro 50, Seoul, South Korea

[2] Sungkyunkwan Univ, Sch Med, Dept Precis Med, Suwon, South Korea

[3] Sungkyunkwan Univ, Sch Med, Dept Med AI, Suwon, South Korea

来源：

OPHTHALMOLOGY | 2024年 / 131卷 / 07期

基金：

新加坡国家研究基金会;

关键词：

immune checkpoint inhibitor; skin melanoma; uveitis; MELANOMA;

D O I：

10.1016/j.ophtha.2024.03.017

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

[No abstract available]

引用

页码：867 / 869

页数：3

共 7 条

[1] CHECKPOINT INHIBITOR IMMUNE THERAPY Systemic Indications and Ophthalmic Side Effects [J].

Dalvin, Lauren A. ;

Shields, Carol L. ;

Orloff, Marlana ;

Sato, Takami ;

Shields, Jerry A. .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (06) :1063-1078

[2] Vitiligo induced by immune checkpoint inhibitors in melanoma patients: an expert opinion [J].

Lommerts, Janny E. ;

Bekkenk, Marcel W. ;

Luiten, Rosalie M. .

EXPERT OPINION ON DRUG SAFETY, 2021, 20 (08) :883-888

[3] Efficacy and safety of two doses of pemetrexed supplemented with folic acid and vitamin B12 in previously treated patients with non-small cell lung cancer [J].

Ohe, Yuichiro ;

Ichinose, Yukito ;

Nakagawa, Kazuhiko ;

Tamura, Tomohicle ;

Kubota, Kaoru ;

Yamamoto, Nobuyuki ;

Adachi, Susumu ;

Nambu, Yoshihiro ;

Fujimoto, Toshio ;

Nishiwaki, Yutaka ;

Saijo, Nagahiro ;

Fukuoka, Masahiro .

CLINICAL CANCER RESEARCH, 2008, 14 (13) :4206-4212

[4] Nivolumab in Previously Untreated Melanoma without BRAF Mutation [J].

Robert, Caroline ;

Long, Georgina V. ;

Brady, Benjamin ;

Dutriaux, Caroline ;

Maio, Michele ;

Mortier, Laurent ;

Hassel, Jessica C. ;

Rutkowski, Piotr ;

McNeil, Catriona ;

Kalinka-Warzocha, Ewa ;

Savage, Kerry J. ;

Hernberg, Micaela M. ;

Lebbe, Celeste ;

Charles, Julie ;

Mihalcioiu, Catalin ;

Chiarion-Sileni, Vanna ;

Mauch, Cornelia ;

Cognetti, Francesco ;

Arance, Ana ;

Schmidt, Henrik ;

Schadendorf, Dirk ;

Gogas, Helen ;

Lundgren-Eriksson, Lotta ;

Horak, Christine ;

Sharkey, Brian ;

Waxman, Ian M. ;

Atkinson, Victoria ;

Ascierto, Paolo A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :320-330

[5] Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update [J].

Schneider, Bryan J. ;

Naidoo, Jarushka ;

Santomasso, Bianca D. ;

Lacchetti, Christina ;

Adkins, Sherry ;

Anadkat, Milan ;

Atkins, Michael B. ;

Brassil, Kelly J. ;

Caterino, Jeffrey M. ;

Chau, Ian ;

Davies, Marianne J. ;

Ernstoff, Marc S. ;

Fecher, Leslie ;

Ghosh, Monalisa ;

Jaiyesimi, Ishmael ;

Mammen, Jennifer S. ;

Naing, Aung ;

Nastoupil, Loretta J. ;

Phillips, Tanyanika ;

Porter, Laura D. ;

Reichner, Cristina A. ;

Seigel, Carole ;

Song, Jung-Min ;

Spira, Alexander ;

Suarez-Almazor, Maria ;

Swami, Umang ;

Thompson, John A. ;

Vikas, Praveen ;

Wang, Yinghong ;

Weber, Jeffrey S. ;

Funchain, Pauline ;

Bollin, Kathryn .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (36) :4073-+

[6] Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry [J].

Sun, Michel M. ;

Kelly, Scott P. ;

Mylavarapu, Apoorva L. ;

Holland, Gary N. ;

Coleman, Anne L. ;

Yu, Fei ;

Hsu, Stephen ;

Lum, Flora ;

Gordon, Lynn K. .

OPHTHALMOLOGY, 2021, 128 (06) :910-919

[7] Drug-Induced Uveitis Related to Checkpoint Inhibitors and MAP-kinase Inhibitors [J].

Thibault, Thomas ;

BEN Ghezala, Ines ;

Freppel, Romane ;

Rajillah, Abdessamad ;

Boulay, Charlene ;

Brunel, Pierre ;

Atzenhoffer, Marina ;

Auvens, Clement ;

Devilliers, Herve ;

Grandvuillemin, Aurelie .

OPHTHALMOLOGY, 2024, 131 (02) :249-251

← 1 →